Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...
Claude Code dynamic workflows are now generally available on all paid plans, including Pro for the first time. The feature writes its own orchestration scripts and coordinates up to 1,000 parallel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results